Feng S, Xie X, Li J, Xu X, Chen C, Zou G, et al
Trelagliptin (syr-472, zafatek), novel once-weekly treatment for type 2 diabetes, inhibits dipeptidyl peptidase-4 (dpp-4) via a non-covalent mechanism
Wegovy Wegovy was the first semaglutide drug approved for obesity
Like so many biohackers before me, I began by doing my own research on Reddit and stumbled upon a thread recommending a supposedly Toronto-based company called Growth Guys. The site claimed BPC-157 could help activate cells involved in tissue repair, including muscles, tendons, ligaments and the gastrointestinal tract, stimulating the synthesis of growth factors, and inhibiting inflammation. It featured a third-party lab report, claiming the compound was 99.88 per cent pure